Received Mar 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | Y010045 | OT |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | — | — |
No adverse event; improper storage of prouct in use; improper storage of product in use; This spontaneous report was received from a pharmacist referring to a patient of unknon age and gender. Information regarding the patient's concurrent conditions, historical conditions and concomitant or historical medications was not provided. On an unspecified date, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) injection for prophylaxis, 0.5 milliliters, subcutaneously, lot number Y010045 which has been verified to be valid, expiration date reported and validated as 29-MAY-2026. The vaccine was reconstituted with sterile diluent Solution for injection (BAXTER STERILE DILUENT) The administered dose of the vaccine was stored at 59.4 Farenheit (F), during one hour and 30 minutes. There were not previous temperature excursions for which details were unknown. There were no symptoms reported.